APA (7th ed.) Citation

Gerischer, L., Stascheit, F., Mönch, M., Doksani, P., Dusemund, C., Herdick, M., . . . Meisel, A. (2026). Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab. Annals of Clinical & Translational Neurology, 13(4), 688. https://doi.org/10.1002/acn3.70251

Chicago Style (17th ed.) Citation

Gerischer, Lea, et al. "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab." Annals of Clinical & Translational Neurology 13, no. 4 (2026): 688. https://doi.org/10.1002/acn3.70251.

MLA (9th ed.) Citation

Gerischer, Lea, et al. "Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab." Annals of Clinical & Translational Neurology, vol. 13, no. 4, 2026, p. 688, https://doi.org/10.1002/acn3.70251.